Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
U should see yahoo mb for laughs shorts are shaking in their boots making up posts lol
My one of my plays for 2016 glad I loaded back some shares holding not selling
Am I correct in thinking the shorts are trying like mad now (with all the good news) to cover before totally creamed in CERS rise? That this is the reason the SP is down near the end of Monday's trading at $6.30? Me wonders.
9.40 looks good from here just on neckline breakut,but thats just a start i would imagine.
$CERS recent news/filings
bullish 6.35
resistance breakout
## source: finance.yahoo.com
Thu, 10 Dec 2015 13:59:36 GMT ~ Cerus Announces Agreement with the National Transfusiology Center of Mongolia for the Use of INTERCEPT Platelets and Plasma
[at noodls] - CONCORD, Calif.--(BUSINESS WIRE)-- Cerus Corporation (NASDAQ: CERS) announced today that the National Transfusiology Center (NTC) of Mongolia has signed a purchase agreement for the INTERCEPT Blood System ...
read full: http://www.noodls.com/view/EE0EDB937A498D46A55571A20750D9E286DA1789
*********************************************************
Thu, 10 Dec 2015 13:32:00 GMT ~ Cerus Announces Agreement with the National Transfusiology Center of Mongolia for the Use of INTERCEPT Platelets and Plasma
[Business Wire] - CONCORD, Calif.--(BUSINESSWIRE)-- Cerus Corporation (NASDAQ: CERS) announced today that the National Transfusiology Center (NTC) of Mongolia has signed a purchase agreement for the INTERCEPT Blood System ...
read full: http://au.finance.yahoo.com/news/cerus-announces-agreement-national-transfusiology-133200634.html
*********************************************************
Thu, 10 Dec 2015 13:32:00 GMT ~ Cerus Announces Agreement with the National Transfusiology Center of Mongolia for the Use of INTERCEPT Platelets and Plasma
[Business Wire] - Cerus Corporation announced today that the National Transfusiology Center of Mongolia has signed a purchase agreement for the INTERCEPT Blood System for platelets and plasma.
read full: http://finance.yahoo.com/news/cerus-announces-agreement-national-transfusiology-133200550.html
*********************************************************
Wed, 09 Dec 2015 13:43:29 GMT ~ Cerus Announces Agência Nacional de Vigilância Sanitária Approval of the INTERCEPT Blood System for Platelets and Plasma in Brazil
[at noodls] - CONCORD, Calif.--(BUSINESS WIRE)-- Cerus Corporation (NASDAQ:CERS) today announced that the INTERCEPT Blood System for platelets and plasma has been approved for commercialization in Brazil by the Agência ...
read full: http://www.noodls.com/view/585BA11D6BE9AF332EC8A9E39B2EC6DD03843629
*********************************************************
Wed, 09 Dec 2015 13:35:00 GMT ~ 8:35 am Cerus announces that the INTERCEPT Blood System for platelets and plasma has been approved for commercialization in Brazil by the Agncia Nacional de Vigilncia Sanitria
read full: http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#cers
*********************************************************
$CERS charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$CERS company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/CERS/company-info
Ticker: $CERS
OTC Market Place: Not Available
CIK code: 0001020214
Company name: Cerus Corp.
Incorporated In: DE, USA
$CERS share structure
## source: otcmarkets.com
Market Value: $603,712,850 a/o Dec 10, 2015
Shares Outstanding: 97,138,029 a/o Oct 30, 2015
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.001
$CERS extra dd links
Company name: Cerus Corp.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/CERS/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/CERS/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=CERS+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=CERS+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=CERS+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/CERS/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/CERS/news - http://finance.yahoo.com/q/h?s=CERS+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/CERS/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/CERS/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/CERS/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/CERS/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/CERS/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/CERS/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/CERS/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/CERS/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=CERS+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/CERS
DTCC (dtcc.com): http://search2.dtcc.com/?q=Cerus+Corp.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Cerus+Corp.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Cerus+Corp.&x=0&y=0
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/CERS/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/CERS
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/CERS/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/CERS/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/CERS/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001020214&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/CERS/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/CERS/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/CERS/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/CERS/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=CERS&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=CERS
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/CERS/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=CERS+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=CERS+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=CERS
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=CERS
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=CERS+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/CERS/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=CERS+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/CERS.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=CERS
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/CERS/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/CERS/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/CERS/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/CERS/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/CERS
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/CERS
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/CERS:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=CERS
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=CERS
$CERS DD Notes ~ http://www.ddnotesmaker.com/CERS
Another new contract this morn
From overseas??????????????
Hot damn cersssssssssssss I'm holding my baby
It just says pre market after market trading in ihub
Wait lol I just saying what's with the weird trade action last couple days?????
Would you sell at $50 or wait for $100 or $200 as occurred with PCYC at a $265 final buyout?
Holding strong come on 50.00$
I close my eyes glad I didn't sell all. I'll ignore this till Nov. Quarterly may have a setback..
I cannot blame you for not watching until November. However, the thrill of the twisties and turns this stock takes is no less an adrenalin rush than a good motorcycle track day. Fun to watch for me.
I bought back in I didn't sell all my shares. I don't watch this one much anymore see ya in Nov.
Bonfils just bought into the Intercept system. Especially good for the image of CERS because of the wealthy and specialty surgery industry. Colorado is one major stamp of acceptance by the public.
Could be a replay of April 23 and 24 only to zoom down the next week. Should be interesting to see if there is a rise from here on Mon thru Fri next week. A few sales reps may have brought in one or two blood banks and news got out from the bar room celebration? If so, 'bout damn time ;>)
$CERS recent news/filings
bullish
## source: finance.yahoo.com
Fri, 29 May 2015 12:51:00 GMT ~ 5 Stocks Under $10 Ready to Spike Higher
read full: http://www.thestreet.com/story/13167752/1/5-stocks-under-10-ready-to-spike-higher.html?puc=yahoo&cm_ven=YAHOO
*********************************************************
Fri, 15 May 2015 17:04:30 GMT ~ CERUS CORP Financials
read full: http://finance.yahoo.com/q/is?s=cers
*********************************************************
Mon, 11 May 2015 00:11:51 GMT ~ 10-Q for Cerus Corp.
read full: http://www.companyspotlight.com/routers/headline/25247/10004/6514346?cp_code=YAH1&1431303111
*********************************************************
Fri, 08 May 2015 20:17:31 GMT ~ CERUS CORP Files SEC form 10-Q, Quarterly Report
read full: http://biz.yahoo.com/e/150508/cers10-q.html
*********************************************************
Tue, 05 May 2015 22:23:28 GMT ~ Cerus Corporation Reports First Quarter 2015 Results
[at noodls] - 05/05/2015 CONCORD, Calif.--(BUSINESS WIRE)-- Cerus Corporation (NASDAQ: CERS) today announced financial results for the first quarter ended March 31, 2015. Recent company highlights include: Signed INTERCEPT ...
read full: http://www.noodls.com/view/7EC53817E44959CE70CCC85FE52F69FAD03B8F79
*********************************************************
$CERS charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$CERS company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/CERS/company-info
Ticker: $CERS
OTC Market Place: Not Available
CIK code: 0001020214
Company name: Cerus Corp.
Incorporated In: DE, USA
$CERS share structure
## source: otcmarkets.com
Market Value: $469,225,369 a/o May 28, 2015
Shares Outstanding: 95,371,010 a/o Apr 30, 2015
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.001
$CERS extra dd links
Company name: Cerus Corp.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/CERS/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/CERS/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=CERS+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=CERS+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=CERS+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/CERS/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/CERS/news - http://finance.yahoo.com/q/h?s=CERS+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/CERS/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/CERS/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/CERS/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/CERS/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/CERS/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/CERS/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/CERS/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/CERS/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=CERS+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/CERS
DTCC (dtcc.com): http://search2.dtcc.com/?q=Cerus+Corp.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Cerus+Corp.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Cerus+Corp.&x=0&y=0
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/CERS/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/CERS
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/CERS/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/CERS/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/CERS/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001020214&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/CERS/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/CERS/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/CERS/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/CERS/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=CERS&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=CERS
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/CERS/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=CERS+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=CERS+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=CERS
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=CERS
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=CERS+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/CERS/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=CERS+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/CERS.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=CERS
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/CERS/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/CERS/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/CERS/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/CERS/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/CERS
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/CERS
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/CERS:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=CERS
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=CERS
$CERS DD Notes ~ http://www.ddnotesmaker.com/CERS
WOW, sure is lonely out here. Nobody to talk to. Everyone must have their face buried in the ticker.
Might be a good day late Tuesday May 5 but the last quarter report was poor at best. Best to all and here is to PCYC number II. Cheers!!!
As if you may not already know or have read this, early this morning....
The Street Quant, for what it is worth.....
Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.
Trade-Ideas LLC identified Cerus ( CERS) as a strong on high relative volume candidate. In addition to specific proprietary factors, Trade-Ideas identified Cerus as such a stock due to the following factors:
CERS has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $4.9 million.
CERS has traded 446,888 shares today.
CERS is trading at 7.51 times the normal volume for the stock at this time of day.
CERS is trading at a new high 4.03% above yesterday's close.
'Strong on High Relative Volume' stocks are worth watching because major volume moves tend to indicate underlying activity such as M&A events, material stock news, analyst upgrades, insider buying, buying from 'superinvestors,' or that hedge funds and momentum traders are piling into a stock ahead of a catalyst. Regardless of the impetus behind the price and volume action, when a stock moves with strength and volume it can indicate the start of a new trend on which early investors can capitalize. In the event of a well-timed trading opportunity, combining technical indicators with fundamental trends and a disciplined trading methodology should help you take the first steps towards investment success.
Most probably there is a good result coming for the first quarter in the number of blood banks coming on board. All it takes is one sales person buying their 'incentive' car or drunk at a bar, for some person to take that indirect communication to the bank.
Controlling the inner workings of a company is easy compared to controlling the field sales, especially if they are green hires.
I bought my shares long ago and could care less. Unless there is WW III or the officers are massively corrupt... this stock will go vertical at any time.
But what is causing the rise????
Also, let's not get too excited - remember, we were at $8.00 about a year ago.
11:32 am and up $.50. Smells delicious... I like cream and sugar with my morning cup of coffee and the rise in CERS share price.
What makes you say this? One of the (many) frustrating aspects of owning this stock is when the price goes up, there is no news or explanation for the price spike (when it goes down, it is because it has failed to meet earnings estimates).
Something is brewing and it smells very good. Thursday, April 23 might just be a great beginning.
Minus .20 and a strong dollar eating into European profits? Seems like back to the $3 bill for CERS, for a while. Hang in there..... time to buy?
Wow this came back lol
Totally agree. Long and holding. Not much anyone can do, so the day traders and shorts are having a flea feast on a huge potential cash cow's hide. I will leave it at that for now. Hang in there.
What is it with this stock? Good product, good technology, Baker Brothers had been loading up on the stock last year - but several misses on street estimates and we have a stock that has lost over half its value in the course of one calendar year.
It would be welcome if the Officers or Board of Directors would provide some guidance as to when they could expect to meet or exceed the street's estimates (or dare I say turn a profit). I know that prior FDA decisions have caused a drag on the stock - but still....
Full disclosure - I am long on the stock and not looking to sell (yet)...
Its coming with warrants bonuses and piss poor management......
$1.85 per share might tempt me to buy a bit more..... I do have my doubts that will happen though. I am set and happy for now.
Nope I doubt it....they have their salaries set with bonuses. They dont care. Ill buy back at 1.85 and ride it up again in November.....
Yep. "The beating will continue until morale improves". In a vacuum of no additional blood bank contracts, the price will continue to fall. Buy, buy , buy. Hope Obi Greenman secures those incoming sales prospect calls, about which he openly mused during the Q4/EOY report.... about 4 or 6 contracts would do.......... for the moment.
I bought any# I'm buying more any# Monday. Not gonna hold back I'm all in on any#. This will be back in the 3.00s or less. I still have a few left will load next yr...
A brave decision for you. Glad you at least made some profit from your investment. On the other hand, even with the delays of profitability, it will be most interesting to see if the worlds blood centers beat a path to the Cerus door. Sweden, Delmarva and Sun Coast are harbingers of what is to come. I am still in for the long slog.
Management sux I sold for a little profit. I'll be back in 2016 after RBC trial is done. This is toast their rev is weak and the euro rev is continually tanking dead dead dead look out another 50lb hemorrhoid falls out another misled investor....
Its not bs look at the news section on ihub under cers there is a ct order
Its dated 2/6/15 ct order it won't open I guess its sealed
Moneyfrog, another well placed question, nicely done. Awesome A, yes the report seems disappointing. I will take this quote from Obi Greenman to the bank in $10 bills and leave the shorts to scramble for the penny dropped...."we do have a lot of inbound calls, which is nice. It's not a traditional sort of sales effort."
Its not bs look at the news section on ihub under cers there is a ct order
Both things you posted were untrue. Why did you post them ? Stock may tank or may not. [ early dip is likely]. Fact is you need to be real careful posting BS on public message boards and then trade around the untruths you posted .
Its not bs I haven't seen the ct document I just saw it on I hub. This is toast I'm selling buying back later the pps I'd gonna tank hard tomorrow....
So was your post #177 BS or have you found the links to support your claims?
Thanks
It is only two as of right now lol I c 4.00$ and change coming I'll reload at 3.45 3.90 and glad I took profits....
Lol letcthe dumping begin baker bros......
While I agree the Company's plans, marketing and sales initiatives are "spot on", at some point the Company has to meet the street's expectations. I know that there are costs involved in marketing and getting FDA approval - but the results released today can only be described as disappointing.
Well put question Monkeyfrog..... I am looking forward to the news from Obi Greenman at 16:15 today for the quarter and year end wrap. My feeling is that they have been keeping the sales numbers very close to their corporate chest. The release of Sun Coast and Delmarva blood bank's adoption of the Cerus Inactivation system are a teaser of that to come. I cannot believe those are the only two about which I will hear over the next 24 hours. Bad surprises do happen. However, I feel their plans, marketing and sales drive are spot on.
Can you link the ct order and where you saw the pathogen reduction instead of inactivation? Thanks!
From the website
The nucleic acid targeting mechanism of action of the INTERCEPT treatment is designed to inactivate established transfusion threats, such as hepatitis B and C, HIV, West Nile virus and bacteria, as well as emerging pathogens such as Chikungunya, malaria and dengue.
Followers
|
42
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
329
|
Created
|
05/30/09
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |